Personnel Today
  • OHW+
  • Resources
    • Clinical governance
    • Disability
    • Ergonomics
    • Health surveillance
    • OH employment law
    • OH service delivery
    • Research
    • Return to work and rehabilitation
    • Sickness absence management
    • Wellbeing and health promotion
  • Conditions
    • Mental health
    • Musculoskeletal disorders
    • Blood pressure
    • Cancer
    • Cardiac
    • Dementia
    • Diabetes
    • Respiratory
    • Stroke
  • CPD
  • Webinars
  • Jobs
  • Personnel Today

Register
Log in
Personnel Today
  • OHW+
  • Resources
    • Clinical governance
    • Disability
    • Ergonomics
    • Health surveillance
    • OH employment law
    • OH service delivery
    • Research
    • Return to work and rehabilitation
    • Sickness absence management
    • Wellbeing and health promotion
  • Conditions
    • Mental health
    • Musculoskeletal disorders
    • Blood pressure
    • Cancer
    • Cardiac
    • Dementia
    • Diabetes
    • Respiratory
    • Stroke
  • CPD
  • Webinars
  • Jobs
  • Personnel Today

Fit for WorkCoronavirusDisabilityLong CovidReturn to work and rehabilitation

Long Covid leaves ‘tell-tale’ traces of inflammation in the blood – study

by Nic Paton 12 Apr 2024
by Nic Paton 12 Apr 2024 People with long Covid have 'tell-tale' patterns of inflammation detectable in the blood, research has concluded
Shutterstock
People with long Covid have 'tell-tale' patterns of inflammation detectable in the blood, research has concluded
Shutterstock

People with long Covid have tell-tale, distinct patterns of inflammation detectable in the blood, which could potentially be targeted with immune therapies, research has suggested.

The findings come from the largest UK study of patients hospitalised with Covid-19 infection, and show that long Covid leads to ongoing inflammation that can be detected in the blood.

In an analysis of more than 650 people who had been hospitalised with severe Covid-19, patients with prolonged symptoms showed evidence of immune system activation.

The exact pattern of this activation varied depending on the sort of symptoms they predominantly had, for example, whether they experienced mainly fatigue or cognitive impairment.

The research, led by clinicians at Imperial College London, suggests that existing drugs that modulate the body’s immune system could be helpful in treating long Covid, and they argued this should be investigated in future clinical trials.

The study, published in the journal Nature Immunology, is the latest research from two collaborative UK-wide consortia, PHOSP-COVID and ISARIC-4C.

Long Covid

Long Covid can have ‘objectively measurable’ effect on brain

Leaky blood vessels could be key to long Covid ‘brain fog’

Long Covid: Being vaccinated ‘consistently’ reduces risk, study finds

These involve scientists and clinicians from Imperial alongside collaborators from the universities of Leicester, Edinburgh and Liverpool among others.

The research has been funded by UK Research and Innovation (UKRI) and the National Institute for Health and Care Research (NIHR).

Professor Peter Openshaw, from Imperial’s National Heart and Lung Institute and an ISARIC-4C lead investigator, said: “With one in ten SARS-CoV-2 infections leading to long Covid and an estimated 65 million people around the world suffering from ongoing symptoms, we urgently need more research to understand this condition.

“At the moment, it’s very hard to diagnose and treat. This study, which includes detailed clinical data on symptoms and a raft of inflammatory blood plasma markers, is an important step forward and provides crucial insights into what causes long Covid.”

In the latest study, researchers included a total of 426 people who were experiencing symptoms consistent with long Covid. These people had been admitted to hospital with Covid-19 infection at least six months prior to the study.

They were compared with 233 people who were also hospitalised for Covid-19 but who had fully recovered.

The researchers took samples of blood plasma and measured a total of 368 proteins known to be involved in inflammation and immune system modulation.

They found that, relative to patients who had fully recovered, those with long Covid showed a pattern of immune system activation. This indicated inflammation of myeloid cells and activation of a family of immune system proteins called ‘the complement system’.

Myeloid cells are formed in the bone marrow. The cells produce various types of white blood cells that circulate in the blood and migrate into organs and tissues where they respond to damage and infection.

The complement system consists of a cascade of linked proteins that are activated in response to infection or tissue damage. Notably, overactivation of the complement system is known to be associated with many autoimmune and inflammatory conditions.

Dr Felicity Liew, a Medical Research Council clinical training fellow from Imperial’s National Heart and Lung Institute, said: “Our findings indicate that complement activation and myeloid inflammation could be a common feature of long Covid after hospitalisation, regardless of symptom type.

“It is unusual to find evidence of ongoing complement activation several months after acute infection has resolved, suggesting that long Covid symptoms are a result of active inflammation.

“However, we can’t be sure that this is applicable to all types of long Covid, especially if symptoms occur after non-hospitalised infection.”

The researchers were also able to obtain comprehensive information about the range of symptoms that patients were experiencing, and which ones were most common.

They found that certain groups of symptoms appeared to be associated with specific proteins. For example, people with gastrointestinal symptoms had increased levels of a marker called SCG3, which has previously been linked to impaired communication between the gut and the brain.

Overall, there were five overlapping subtypes of long Covid with different immune signatures, despite some commonalities, namely:

  • fatigue
  • cognitive impairment
  • anxiety and depression
  • cardiorespiratory
  • gastrointestinal

The researchers stress, however, that these groups are not mutually exclusive, and people can fall between groups depending on their symptoms.

Nevertheless, these long Covid subtypes seem to represent clear biological mechanisms of disease and highlight that different symptoms may have different underlying causes.

The researchers suggest this could be useful in designing clinical trials, especially for treatments that target immune responses and inflammation.

This work provides strong evidence that long Covid is caused by post-viral inflammation but shows layers of complexity.” – Professor Peter Openshaw, Imperial College National Heart and Lung Institute

One such treatment could include drugs called IL-1 antagonists, such as anakinra, which is commonly used to treat rheumatoid arthritis,  as well as another drug class called JAK inhibitors, used to treat some types of cancers and severe forms of rheumatoid arthritis.

Both drug types work by targeting components of the immune system that might be activated in long Covid.

The researchers highlight that one limitation of their study was that it only included people who had severe Covid infections and who were hospitalised as a result.

Yet a sizeable proportion of people who develop long Covid in the wider population only report mild initial Covid infection. It is unclear if the same immune mechanisms are at work.

Professor Openshaw concludes: “This work provides strong evidence that long Covid is caused by post-viral inflammation but shows layers of complexity.

Sign up to our weekly round-up of HR news and guidance

Receive the Personnel Today Direct e-newsletter every Wednesday

OptOut
This field is for validation purposes and should be left unchanged.

“We hope that our work opens the way to the development of specific tests and treatments for the various types of long Covid and believe that a ‘one size fits all’ approach to treatment may not work.

“Covid-19 will continue to have far reaching effects long after the initial infection has passed, impacting many lives. Understanding what’s happening in the body, and how the immune system responds, is key to helping those affected,” he added.

Nic Paton

Nic Paton is consultant editor at Personnel Today. One of the country's foremost workplace health journalists, Nic has written for Personnel Today and Occupational Health & Wellbeing since 2001, and edited the magazine from 2018.

previous post
Study linking ethnic diversity with performance questioned by academics
next post
Charity warns of sharp delays in compensation for mesothelioma

You may also like

Working days lost to asthma up 150% since...

4 Apr 2025

Five years on: how has work changed since...

12 Mar 2025

Long Covid costing UK plc billions in lost...

10 Dec 2024

Long Covid: How, slowly, I found solutions that...

2 Dec 2024

Pain the most common symptom of long Covid...

20 Sep 2024

Long Covid cognitive and psychiatric problems can last...

31 Jul 2024

Study makes case for sick pay rethink to...

11 Jul 2024

People with long Covid being failed by return-to-work...

15 Apr 2024

Covid vaccinations do protect against heart failure and...

15 Mar 2024

Health workers take long Covid claim to High...

6 Mar 2024

  • 2025 Employee Communications Report PROMOTED | HR and leadership...Read more
  • The Majority of Employees Have Their Eyes on Their Next Move PROMOTED | A staggering 65%...Read more
  • Prioritising performance management: Strategies for success (webinar) WEBINAR | In today’s fast-paced...Read more
  • Self-Leadership: The Key to Successful Organisations PROMOTED | Eletive is helping businesses...Read more
  • Retaining Female Talent: Four Ways to Reduce Workplace Drop Out PROMOTED | International Women’s Day...Read more

PERSONNEL TODAY

About us
Contact us
Browse all HR topics
Email newsletters
Content feeds
Cookies policy
Privacy policy
Terms and conditions

JOBS

Personnel Today Jobs
Post a job
Why advertise with us?

EVENTS & PRODUCTS

The Personnel Today Awards
The RAD Awards
Employee Benefits
Forum for Expatriate Management
OHW+
Whatmedia

ADVERTISING & PR

Advertising opportunities
Features list 2025

  • Facebook
  • Twitter
  • Instagram
  • Linkedin


© 2011 - 2025 DVV Media International Ltd

Personnel Today
  • OHW+
  • Resources
    • Clinical governance
    • Disability
    • Ergonomics
    • Health surveillance
    • OH employment law
    • OH service delivery
    • Research
    • Return to work and rehabilitation
    • Sickness absence management
    • Wellbeing and health promotion
  • Conditions
    • Mental health
    • Musculoskeletal disorders
    • Blood pressure
    • Cancer
    • Cardiac
    • Dementia
    • Diabetes
    • Respiratory
    • Stroke
  • CPD
  • Webinars
  • Jobs
  • Personnel Today